Rayvolve is the first French CE-marked algorithmic AI tool designed for use in standard radiology. It saves time and improves accuracy for radiologists. AZmed‘s Rayvolve software is now available on … Read more
The medical device created by the Breton company Hemarina is revolutionizing organ and tissue transplantation thanks to the oxygen transport capacities of the Arenicola marina lugworm. 14 hours of … Read more
To speed the discovery of drug candidates for scleroderma, a rare autoimmune disease, 4P-Pharma will make use of the artificial intelligence platform developed by Oncocross. The cooperation agreement has just … Read more
The French Treasury Department has granted a €32.2 million concessional loan to Kenya to finance the installation of high-performance medical equipment. The main contractor, FSE, is bringing in around 40 … Read more
The software developed by the Institut Curie and Institut Pasteur spin-off offers surgeons a 3D visualization of breast tumors using a virtual reality headset. In 2020, 685,000 women died from … Read more
The world’s leading biopharmacy firms have issued a joint statement promising to reduce their CO2 emissions and invest in greener energy sources. Speaking on the sidelines of COP 26, which … Read more
On September 30, 2021, the American Hospital of Paris launched the Medical Talent by American Hospital of Paris program, in partnership with African hospitals. Through its program, the American Hospital … Read more
As part of the new series of practical workshops proposed by French Healthcare Association for its members and in the perspective of supporting them in the expansion of their competences … Read more
A first in East Africa: the city of Djibouti has chosen the eco-friendly anti-mosquito solution of the young French company QISTA to fight against the mosquitoes responsible for the transmission … Read more
With 220 members – companies and healthcare institutions – in November, French Healthcare Association continues its strong growth. New member, Enovacom, through the voice of its export sales director Simon Chassain, expressed its expectations.
The artificial heart developed by Carmat has been marketed in Italy and Germany since July 2021. It has already been implanted in around thirty patients. France’s high-speed train (the TGV), … Read more
The health tech firm is entering the American market with its unified in silico clinical trial simulation platform, Jinkō. Novadiscovery is continuing its international expansion by opening a new office … Read more